BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32282791)

  • 1. Improving the coverage of credible sets in Bayesian genetic fine-mapping.
    Hutchinson A; Watson H; Wallace C
    PLoS Comput Biol; 2020 Apr; 16(4):e1007829. PubMed ID: 32282791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian fine-mapping model using a continuous global-local shrinkage prior with applications in prostate cancer analysis.
    Li X; Sham PC; Zhang YD
    Am J Hum Genet; 2024 Feb; 111(2):213-226. PubMed ID: 38171363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic fine-mapping from summary data using a nonlocal prior improves the detection of multiple causal variants.
    Karhunen V; Launonen I; Järvelin MR; Sebert S; Sillanpää MJ
    Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37348543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses.
    Yang Z; Wang C; Liu L; Khan A; Lee A; Vardarajan B; Mayeux R; Kiryluk K; Ionita-Laza I
    Nat Genet; 2023 Jun; 55(6):1057-1065. PubMed ID: 37169873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for 12 immune-mediated diseases.
    Kundu K; Tardaguila M; Mann AL; Watt S; Ponstingl H; Vasquez L; Von Schiller D; Morrell NW; Stegle O; Pastinen T; Sawcer SJ; Anderson CA; Walter K; Soranzo N
    Nat Genet; 2022 Mar; 54(3):251-262. PubMed ID: 35288711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-ranking sequencing variants in the post-GWAS era for accurate causal variant identification.
    Faye LL; Machiela MJ; Kraft P; Bull SB; Sun L
    PLoS Genet; 2013; 9(8):e1003609. PubMed ID: 23950724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of the Laplace effect size prior distribution in Bayesian fine-mapping studies.
    Walters K; Cox A; Yaacob H
    Genet Epidemiol; 2021 Jun; 45(4):386-401. PubMed ID: 33410201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flashfm approach for fine-mapping multiple quantitative traits.
    Hernández N; Soenksen J; Newcombe P; Sandhu M; Barroso I; Wallace C; Asimit JL
    Nat Commun; 2021 Oct; 12(1):6147. PubMed ID: 34686674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple SNP Set Analysis for Genome-Wide Association Studies Through Bayesian Latent Variable Selection.
    Lu ZH; Zhu H; Knickmeyer RC; Sullivan PF; Williams SN; Zou F;
    Genet Epidemiol; 2015 Dec; 39(8):664-77. PubMed ID: 26515609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SparsePro: An efficient fine-mapping method integrating summary statistics and functional annotations.
    Zhang W; Najafabadi H; Li Y
    PLoS Genet; 2023 Dec; 19(12):e1011104. PubMed ID: 38153934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Performance of Fine-Mapping Strategies at Common Variant GWAS Loci.
    van de Bunt M; Cortes A; ; Brown MA; Morris AP; McCarthy MI
    PLoS Genet; 2015; 11(9):e1005535. PubMed ID: 26406328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele-Specific QTL Fine Mapping with PLASMA.
    Wang AT; Shetty A; O'Connor E; Bell C; Pomerantz MM; Freedman ML; Gusev A
    Am J Hum Genet; 2020 Feb; 106(2):170-187. PubMed ID: 32004450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint Bayesian inference of risk variants and tissue-specific epigenomic enrichments across multiple complex human diseases.
    Li Y; Kellis M
    Nucleic Acids Res; 2016 Oct; 44(18):e144. PubMed ID: 27407109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BEATRICE: Bayesian Fine-mapping from Summary Data using Deep Variational Inference.
    Ghosal S; Schatz MC; Venkataraman A
    bioRxiv; 2023 Dec; ():. PubMed ID: 36993396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential genetic causal variants for obesity-related traits using statistical fine mapping.
    Gong R; Greenbaum J; Lin X; Du Y; Su KJ; Gong Y; Shen J; Deng HW
    Mol Genet Genomics; 2023 Nov; 298(6):1309-1319. PubMed ID: 37498361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases.
    Yuan K; Longchamps RJ; Pardiñas AF; Yu M; Chen TT; Lin SC; Chen Y; Lam M; Liu R; Xia Y; Guo Z; Shi W; Shen C; ; Daly MJ; Neale BM; Feng YA; Lin YF; Chen CY; O'Donovan M; Ge T; Huang H
    medRxiv; 2023 Jul; ():. PubMed ID: 36711496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of all-but-one conditional analysis for eQTL isolation in peripheral blood.
    Brown M; Greenwood E; Zeng B; Powell JE; Gibson G
    Genetics; 2023 Jan; 223(1):. PubMed ID: 36321965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and fine-mapping of kidney function loci in first genome-wide association study in Africans.
    Fatumo S; Chikowore T; Kalyesubula R; Nsubuga RN; Asiki G; Nashiru O; Seeley J; Crampin AC; Nitsch D; Smeeth L; Kaleebu P; Burgess S; Nyirenda M; Franceschini N; Morris AP; Tomlinson L; Newton R
    Hum Mol Genet; 2021 Jul; 30(16):1559-1568. PubMed ID: 33783510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of expression QTLs with fine mapping via SuSiE.
    Zhang X; Jiang W; Zhao H
    PLoS Genet; 2024 Jan; 20(1):e1010929. PubMed ID: 38271473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved methods for multi-trait fine mapping of pleiotropic risk loci.
    Kichaev G; Roytman M; Johnson R; Eskin E; Lindström S; Kraft P; Pasaniuc B
    Bioinformatics; 2017 Jan; 33(2):248-255. PubMed ID: 27663501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.